Retrovir Capsules in the Treatment of HIV-Infected Patients in Renal Failure

Not Applicable

Completed

• Conditions: HIV Infections; Kidney Failure, Chronic

• Registration Number: NCT00002047
• Lead Sponsor: Glaxo Wellcome

Brief Summary

To evaluate the safety, tolerance, and pharmacokinetics of Retrovir (AZT) administration in HIV-infected patients in renal failure receiving maintenance hemodialysis.

Detailed Description

Not available

Study Timeline

• Status Verified: 1990-05
• Study First Submitted: 1999-11-02
• Study First Submitted QC: 2001-08-30
• Study First Posted: 2001-08-31
• Last Update Submitted: 2005-06-23
• Last Update Posted: 2005-06-24

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: Not specified

Trial Locations

Locations (1)

Univ of Maryland at Baltimore; 🇺🇸 Baltimore, Maryland, United States